Skip to main content
. Author manuscript; available in PMC: 2018 May 1.
Published in final edited form as: Acta Biomater. 2017 Mar 23;54:249–258. doi: 10.1016/j.actbio.2017.03.032

Figure 3. Long-term viability of hNSCs after nanoparticle-mediated transfection.

Figure 3

Viabilities of Olig1, Olig2, or Olig1/2-transfected hNSCs were inspected by AlamarBlue assay on days 2, 5, 9, 13, and 15, respectively (n = 4; *P < 0.05). Cells without transfection were used as a control.